Indian pharma is on edge with an expected pharma pricing overhaul, but nothing is known yet on the shape of things to come.

CLSA raised its price target to Rs 600 after the pharma firm reported a rise in net profit on May 25, 2018. \"We believe earnings have bottomed out for Sun Pharma,\" CLSA Research said.

Just prior to the results, on May 23, Sun Pharma had announced that the US drug regulator USFDA (US Food and Drug Administration) approved Yonsa, its drug to treat a kind of prostate cancer.

Even as US President Donald Trump wants United States Trade Representative (USTR) to step pressure on the country's trade partners to provide pricing freedom for US based medical device companies, local industry lobby group Association of Indian Manufacturers of Medical Devices (AIMED) has urged India to reduce reliance on imported medical devices.

Through a fog of data, air of Indian cities' looks dirtiestIndia should follow China's example and clean up the air in its cities, which are among the world's worst for outdoor pollution, the World Health Organization said on Wednesday. The WHO's database of more than 4,300 cities showed Indian cities such as New Delhi, Varanasi and Patna were among the most polluted, based on the amount of particulate matter under 2.5 micrograms found in every cubic metre of air.India rejects US ...

India's drug pricing authority is also pushing to bring three more devices used while treating heart ailments under the ambit of price controls as they are sometimes more expensive than the stent itself.

Payment should be based on value, not activities.

National drug pricing regulator NPPA has said medical devices makers and importers are being given the last opportunity to submit data regarding price movement of 19 medical devices notified as drugs by March 15, 2018.

Once known for the books it sold, the e-commerce behemoth has today permeated most lives with products to meet everyday needs - from grocery to gadgets, movies to now even medicines.

Zee Entertainment MD Punit Goenka has always been sceptical about offering content free. The home-grown media conglomerate earlier this week let out its digital strategy with the launch of Zee 5.